CN105283203B - 用于热熔挤出的组合物以及通过使用该组合物制备热熔挤出物的方法 - Google Patents

用于热熔挤出的组合物以及通过使用该组合物制备热熔挤出物的方法 Download PDF

Info

Publication number
CN105283203B
CN105283203B CN201480030211.8A CN201480030211A CN105283203B CN 105283203 B CN105283203 B CN 105283203B CN 201480030211 A CN201480030211 A CN 201480030211A CN 105283203 B CN105283203 B CN 105283203B
Authority
CN
China
Prior art keywords
hot
hpmcas
drug
melt
melt extruded
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201480030211.8A
Other languages
English (en)
Chinese (zh)
Other versions
CN105283203A (zh
Inventor
藁品彰吾
草木史枝
菊池辉
菊池一辉
尾原荣
丸山直亮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shin-Etsu Chemical Co Ltd
Original Assignee
Shin-Etsu Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50842156&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN105283203(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shin-Etsu Chemical Co Ltd filed Critical Shin-Etsu Chemical Co Ltd
Publication of CN105283203A publication Critical patent/CN105283203A/zh
Application granted granted Critical
Publication of CN105283203B publication Critical patent/CN105283203B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00—Preparation of cellulose ethers
    • C08B11/193—Mixed ethers, i.e. ethers with two or more different etherifying groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00—Preparation of cellulose ethers
    • C08B11/20—Post-etherification treatments of chemical or physical type, e.g. mixed etherification in two steps, including purification
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B13/00—Preparation of cellulose ether-esters
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/20—Compounding polymers with additives, e.g. colouring
    • C08J3/201—Pre-melted polymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/08—Cellulose derivatives
    • C08L1/32—Cellulose ether-esters
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2301/00—Characterised by the use of cellulose, modified cellulose or cellulose derivatives
    • C08J2301/08—Cellulose derivatives
    • C08J2301/32—Cellulose ether-esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201480030211.8A 2013-06-03 2014-06-03 用于热熔挤出的组合物以及通过使用该组合物制备热熔挤出物的方法 Active CN105283203B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2013116836 2013-06-03
JP2013-116836 2013-06-03
JP2013246178 2013-11-28
JP2013-246178 2013-11-28
PCT/JP2014/064711 WO2014196519A1 (ja) 2013-06-03 2014-06-03 加熱溶融押出用組成物及びこれを用いた加熱溶融押出成型物の製造方法

Publications (2)

Publication Number Publication Date
CN105283203A CN105283203A (zh) 2016-01-27
CN105283203B true CN105283203B (zh) 2018-12-28

Family

ID=50842156

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201480030211.8A Active CN105283203B (zh) 2013-06-03 2014-06-03 用于热熔挤出的组合物以及通过使用该组合物制备热熔挤出物的方法
CN201410242677.6A Active CN104208713B (zh) 2013-06-03 2014-06-03 用于热熔挤出的组合物以及用其制备热熔挤出产品的方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201410242677.6A Active CN104208713B (zh) 2013-06-03 2014-06-03 用于热熔挤出的组合物以及用其制备热熔挤出产品的方法

Country Status (8)

Country Link
US (2) US10016508B2 (enExample)
EP (2) EP2810660B1 (enExample)
JP (2) JP6126555B2 (enExample)
KR (2) KR102228157B1 (enExample)
CN (2) CN105283203B (enExample)
IN (1) IN2014DE01467A (enExample)
PT (2) PT2810660T (enExample)
WO (1) WO2014196519A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105283203B (zh) * 2013-06-03 2018-12-28 信越化学工业株式会社 用于热熔挤出的组合物以及通过使用该组合物制备热熔挤出物的方法
JP6203702B2 (ja) 2014-11-18 2017-09-27 信越化学工業株式会社 ヒプロメロース酢酸エステルコハク酸エステルを用いたスプレードライ用溶液及び固体分散体の製造方法
EP3998258A1 (en) 2014-12-18 2022-05-18 Merck Sharp & Dohme Corp. (s)-n-(3-(6-isopropoxypyridin-3-yl)-1h-indazol-5-yl)-1-(2-(4-(4-(1-methyl- 1h-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2h)-yl)-2-oxoethyl)-3- (methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations
CN107567462B (zh) * 2015-05-15 2020-10-16 陶氏环球技术有限责任公司 用于制造具有极高分子量和低粘度的酯化纤维素醚的方法
JP6737810B2 (ja) * 2015-05-15 2020-08-12 ダウ グローバル テクノロジーズ エルエルシー 高分子量のエステル化セルロースエーテルを調製するプロセス
KR20180036724A (ko) * 2015-07-28 2018-04-09 다우 글로벌 테크놀로지스 엘엘씨 에스테르화된 셀룰로오스 에테르의 분산물을 생성하는 방법
EP3596132B1 (en) 2017-03-17 2021-05-05 Nutrition & Biosciences USA 1, LLC Process for recovering an esterified cellulose ether from a reaction product mixture
WO2018170083A1 (en) 2017-03-17 2018-09-20 Dow Global Technologies Llc Process for recovering an esterified cellulose ether from a reaction product mixture
WO2018170060A1 (en) 2017-03-17 2018-09-20 Dow Global Technologies Llc Process for recovering an esterified cellulose ether from a reaction product mixture
US20180282527A1 (en) * 2017-03-30 2018-10-04 Shin-Etsu Chemical Co., Ltd. Injection molding composition containing hypromellose acetate succinate and method for producing same
CN109078186B (zh) * 2017-06-14 2021-09-03 江苏恒瑞医药股份有限公司 一种胃漂浮组合物及其制备方法
TR201722852A2 (tr) * 2017-12-29 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Mesalazi̇ni̇n oral farmasöti̇k kompozi̇syonlari
WO2020131801A1 (en) 2018-12-18 2020-06-25 DDP Specialty Electronic Materials US, Inc. A sustained release composition comprising a hydroxypropyl methylcellulose acetate succinate
JP7050714B2 (ja) * 2019-04-04 2022-04-08 信越化学工業株式会社 腸溶性コーティング用組成物及び固形製剤の製造方法
JP7273691B2 (ja) 2019-11-01 2023-05-15 信越化学工業株式会社 ヒドロキシプロピルメチルセルロースフタレートの製造方法
JP7252882B2 (ja) * 2019-11-01 2023-04-05 信越化学工業株式会社 ヒドロキシプロピルメチルセルロースアセテートサクシネートの製造方法
WO2021118915A1 (en) 2019-12-09 2021-06-17 Nutrition & Biosciences Usa 1, Llc Hydroxypropyl alkyl cellulose acetate succinate heteropolymers
EP4196096A1 (en) 2020-08-13 2023-06-21 Alfred E. Tiefenbacher (GmbH & Co. KG) Gastro-resistant high-strength formulation containing posaconazole
JP7399060B2 (ja) * 2020-10-01 2023-12-15 信越化学工業株式会社 ヒドロキシプロピルメチルセルロースアセテートサクシネートの製造方法
EP4091604B1 (en) 2021-11-25 2024-04-03 Alfred E. Tiefenbacher (GmbH & Co. KG) Granules containing posaconazole
CN115581678B (zh) * 2022-11-04 2023-09-12 北京鑫开元医药科技有限公司 一种瑞派替尼片组合物及其制备方法
CN115651085B (zh) * 2022-11-14 2023-11-17 乳源东阳光药业有限公司 一种醋酸羟丙甲纤维素琥珀酸酯的纯化方法
KR102945795B1 (ko) * 2023-10-16 2026-03-30 강원대학교산학협력단 서방형 약물전달체를 유효성분으로 포함하는 염증성 장질환의 예방, 개선 또는 치료용 조성물

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102065842A (zh) * 2008-04-15 2011-05-18 先灵公司 优选含有泊沙康唑和hpmcas的固体分散体形式的口服药物组合物
CN104208713A (zh) * 2013-06-03 2014-12-17 信越化学工业株式会社 用于热熔挤出的组合物以及用其制备热熔挤出产品的方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852421A (en) 1970-03-23 1974-12-03 Shinetsu Chemical Co Excipient and shaped medicaments prepared therewith
US4226981A (en) 1977-09-28 1980-10-07 Shin-Etsu Chemical Co., Ltd. Ether-ester derivatives of cellulose and their applications
JPS5951562B2 (ja) 1977-10-25 1984-12-14 信越化学工業株式会社 セルロ−スエ−テルの酸性サクシニルおよび脂肪族モノアシル混成エステルの製造方法
US4266981A (en) 1978-03-08 1981-05-12 Purdue Research Corporation Process for recovering and utilizing cellulose using sulfuric acid
DE19504832A1 (de) * 1995-02-14 1996-08-22 Basf Ag Feste Wirkstoff-Zubereitungen
AR038375A1 (es) 2002-02-01 2005-01-12 Pfizer Prod Inc Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo
JPWO2003077827A1 (ja) 2002-03-19 2005-07-14 日本新薬株式会社 医薬固体分散体の製造方法
KR100454394B1 (ko) 2002-03-27 2004-10-26 이원희 맥파검출장치
JP4344914B2 (ja) 2003-02-28 2009-10-14 信越化学工業株式会社 アルカリ溶解性カルボン酸エステル系セルロース誘導体及び該誘導体からなるフィルム
EP1753402B1 (en) * 2004-05-28 2008-10-01 Pfizer Products Incorporated Pharmaceutical compositions with enhanced performance comprising a hpmca polymer
CA2621800A1 (en) 2005-09-06 2007-03-15 Astellas Pharma Inc. Fine particles of poorly soluble drug having enteric base material adsorbed on the surface thereof
JP5576922B2 (ja) * 2006-04-20 2014-08-20 信越化学工業株式会社 腸溶性固体分散体を含んでなる固形製剤
JP5070618B2 (ja) * 2006-06-16 2012-11-14 トーアエイヨー株式会社 腸溶性顆粒剤及びその製造方法
JP5052051B2 (ja) * 2006-06-16 2012-10-17 トーアエイヨー株式会社 腸溶性顆粒剤及びその製造方法
CA2666670A1 (en) 2006-10-20 2008-05-02 Dow Global Technologies Inc. Uses of water-soluble cellulose derivatives for preventing or treating metabolic syndrome
EP2278957A2 (en) 2008-04-15 2011-02-02 Schering Corporation Oral pharmaceutical compositions in a solid dispersion comprising preferably posaconazole and hpmcas
EP2927720B1 (en) 2010-02-03 2018-10-17 Tyco Electronics Nederland B.V. Enclosure assembly for a connector, strain relief element, and method
WO2011159626A1 (en) 2010-06-14 2011-12-22 Bend Research, Inc. Hydroxypropyl methyl cellulose acetate succinate with enhanced acetate and succinate substitution
US8409560B2 (en) 2011-03-08 2013-04-02 Zalicus Pharmaceuticals Ltd. Solid dispersion formulations and methods of use thereof
WO2012122279A1 (en) * 2011-03-08 2012-09-13 Zalicus Pharmaceuticals Ltd. Solid dispersion formulations and methods of use thereof
US20120251588A1 (en) * 2011-03-30 2012-10-04 Miyuki Fukasawa Coating Composition, Solid Preparation Coated Therewith, and Method for Preparing Solid Preparation
JP2013116836A (ja) 2011-12-02 2013-06-13 Sharp Corp シリコン端材の再利用方法並びに原料シリコン、多結晶シリコン材料及び多結晶シリコン太陽電池の製造方法
DE102012010430A1 (de) 2012-05-29 2013-12-05 Krohne Ag Durchflussmessgerät
BR112015002055A2 (pt) 2012-08-24 2017-07-04 Dow Global Technologies Llc acetato succinato de hidroxialquil metil celulose, composição, dispersão sólida, processo para produzir uma dispersão sólida, forma de dosagem e cápsula de envoltório

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102065842A (zh) * 2008-04-15 2011-05-18 先灵公司 优选含有泊沙康唑和hpmcas的固体分散体形式的口服药物组合物
CN104208713A (zh) * 2013-06-03 2014-12-17 信越化学工业株式会社 用于热熔挤出的组合物以及用其制备热熔挤出产品的方法

Also Published As

Publication number Publication date
EP2810660B1 (en) 2017-07-26
IN2014DE01467A (enExample) 2015-07-24
KR20160015234A (ko) 2016-02-12
JP2015127316A (ja) 2015-07-09
EP3006049A1 (en) 2016-04-13
US20160095928A1 (en) 2016-04-07
PT2810660T (pt) 2017-08-16
JPWO2014196519A1 (ja) 2017-02-23
EP3006049B1 (en) 2018-02-28
EP3006049A4 (en) 2017-02-22
US20140357681A1 (en) 2014-12-04
US10646573B2 (en) 2020-05-12
WO2014196519A1 (ja) 2014-12-11
EP2810660A1 (en) 2014-12-10
CN105283203A (zh) 2016-01-27
JP6126555B2 (ja) 2017-05-10
US10016508B2 (en) 2018-07-10
PT3006049T (pt) 2018-03-20
KR102228157B1 (ko) 2021-03-17
CN104208713B (zh) 2018-04-27
CN104208713A (zh) 2014-12-17
JP6007322B2 (ja) 2016-10-12
KR101918327B1 (ko) 2018-11-13
KR20140142173A (ko) 2014-12-11

Similar Documents

Publication Publication Date Title
CN104208713B (zh) 用于热熔挤出的组合物以及用其制备热熔挤出产品的方法
EP3023110B2 (en) Solution for spray drying comprising hypromellose acetate succinate and method for producing solid dispersion
EP2837391B1 (en) Hypromellose acetate succinate for use as hot-melt extrusion carrier, hot-melt extrusion composition, and method for producing hot-melt extrudate
JP5224812B2 (ja) 固体分散を連続ポリデキストロース相およびポリデキストロース以外のポリマーの連続相を含むポリマーマトリックスと共に含有する医薬組成物
Choudhari et al. Emerging applications of hydroxypropyl methylcellulose acetate succinate: different aspects in drug delivery and its commercial potential
KR20170114949A (ko) 용해 상태가 우수한 히프로멜로오스 아세트산에스테르 숙신산에스테르 분말 및 그의 제조 방법, 및 고체 분산체용 조성물, 코팅용 조성물, 약물 함유 입자 및 고형 제제의 각 제조 방법
US11767371B2 (en) Hydroxypropyl methyl cellulose acetate succinate, method for producing the same, and composition for hot-melt extrusion
JP2024091760A (ja) 非晶質固体分散体を含む複合物
JP6823002B2 (ja) ヒプロメロース酢酸エステルコハク酸エステルを含む射出成型用組成物及びその製造方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant